CG
DPLO

Cutler Group’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Cutler Group’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-14,200
Closed -$16K – 5091
2019
Q1 		$16K Buy
+14,200
New +$147K ﹤0.01% 2203
2018
Q2 		– Sell
-8,700
Closed -$5K – 5231
2018
Q1 		$5K Hold
8,700
– – ﹤0.01% 3358
2017
Q4 		$7K Buy
8,700
+6,100
+235% +$120K ﹤0.01% 3435
2017
Q3 		$3K Buy
2,600
+2,300
+767% +$38.9K ﹤0.01% 4942
2017
Q2 		$1K Buy
+300
New +$5K ﹤0.01% 6160
2017
Q1 		– Sell
-11,200
Closed -$40K – 7605
2016
Q4 		$40K Buy
+11,200
New +$209K ﹤0.01% 2785
2016
Q3 		– Sell
-900
Closed -$1K – 7707
2016
Q2 		$1K Sell
900
-1,800
-67% -$56.6K ﹤0.01% 6417
2016
Q1 		$7K Buy
2,700
+1,200
+80% +$35.3K ﹤0.01% 4551
2015
Q4 		$1K Buy
+1,500
New +$46.8K ﹤0.01% 6200

Other funds holding DPLO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Cutler Group's DPLO Position: Q1 2020 in Review

Cutler Group sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 300 shares — an estimated $1K sold.

Cutler Group first reported a position in DPLO in Q4 2015 and held it in 9 quarters. The position peaked at $283K in Q4 2016. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.

  • Cutler Group reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
  • Cutler Group sold 300 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $1K.
  • Cutler Group first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2015 and held it in 9 quarters.
  • Cutler Group's DIPLOMAT PHARMACY, INC. position peaked at $283K in Q4 2016.
  • 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.

Based on Cutler Group's 13F filing for Q1 2020, filed 7 May 2020.